Search results

Articles (5)

Journals (0)

1-5 of 5 results for ADCOMS

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published February 20, 2024

ADSS: A Composite Score to Detect Disease Progression in Alzheimer’s Disease

Guogen Shan, Xinlin Lu, Zhigang Li [...]

Journal of Alzheimer's Disease Reports

Restricted accessOtherFirst published September, 1989

ADCOM: Programs for Finding Scale Values for Additive Conjoint Measurement and for Computing All Solutions to a System of Linear Inequalities

Ronald Hübner

Applied Psychological Measurement

Open accessArticle commentaryFirst published April 2, 2024

“Landscape of Phase 2 Trials in Alzheimer’s Disease”: Perspective on Adaptive Trials

Jeffrey Cummings

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published June 25, 2024

Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11β-HSD1 Inhibitor Xanamem ® for Mild Alzheimer’s Disease

Jack Taylor, Mark Jaros, Christopher Chen [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published October, 2023

Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer’s disease: A systematic review

Selia Chowdhury, Nurjahan Shipa Chowdhury

International Journal of Immunopathology and Pharmacology

Search results

Articles (5)

Journals (0)

1-5 of 5 results for ADCOMS

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published February 20, 2024

ADSS: A Composite Score to Detect Disease Progression in Alzheimer’s Disease

Guogen Shan, Xinlin Lu, Zhigang Li [...]

Journal of Alzheimer's Disease Reports

Restricted accessOtherFirst published September, 1989

ADCOM: Programs for Finding Scale Values for Additive Conjoint Measurement and for Computing All Solutions to a System of Linear Inequalities

Ronald Hübner

Applied Psychological Measurement

Open accessArticle commentaryFirst published April 2, 2024

“Landscape of Phase 2 Trials in Alzheimer’s Disease”: Perspective on Adaptive Trials

Jeffrey Cummings

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published June 25, 2024

Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11β-HSD1 Inhibitor Xanamem ® for Mild Alzheimer’s Disease

Jack Taylor, Mark Jaros, Christopher Chen [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published October, 2023

Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer’s disease: A systematic review

Selia Chowdhury, Nurjahan Shipa Chowdhury

International Journal of Immunopathology and Pharmacology